دورية أكاديمية

Antioxidants Delay Clinical Signs and Systemic Effects of ENU Induced Brain Tumors in Rats.

التفاصيل البيبلوغرافية
العنوان: Antioxidants Delay Clinical Signs and Systemic Effects of ENU Induced Brain Tumors in Rats.
المؤلفون: Hervouet, E., Staehlin, O., Pouliquen, D., Debien, E., Cartron, P-F., Menanteau, J., Vallette, F.M., Olivier, C.
المصدر: Nutrition & Cancer; Jul2013, Vol. 65 Issue 5, p686-694, 9p
مصطلحات موضوعية: THERAPEUTIC use of antioxidants, TUMOR prevention, GLIOMAS, ANIMAL experimentation, BIOCHEMISTRY, BRAIN tumors, CELL culture, CLINICAL trials, NUTRITION, POLYMERASE chain reaction, RATS, WESTERN immunoblotting, DATA analysis, DESCRIPTIVE statistics, DIAGNOSIS
مستخلص: According to our previous study suggesting that antioxidant properties of phytochemicals in the diet decrease glioma aggressiveness, we used a SUVIMAX-like diet (“Supplementation en VItamines et Minéraux AntioXydants”) (enriched with alpha-tocopherol, beta carotene, vitamin C, zinc, and sodium selenite), adapted to rats. The present results showed that each of the antioxidants inhibited growth of glioma cells in vitro. When used in combination for in vivo studies, we showed a highly significant delay in the clinical signs of the disease, but not a statistical significant difference in the incidence of glioma in anEthyl-nitrosourea (ENU)-model. The SUVIMAX-like diet decreased candidate markers of tumoral aggressiveness and gliomagenesis progression. The mRNA expressions of 2 common markers in human glioma: Mn-SOD (Manganese Superoxide Dismutase) and IGFBP5 (insulin growth factor binding protein) were reduced in the tumors of rats fed the antioxidant diet. In addition, the transcripts of two markers linked to brain tumor proliferation, PDGFRb (platelet-derived growth factor receptor beta) and Ki-67, were also significantly decreased. On the whole, our results suggest a protective role for antioxidants to limit aggressiveness and to some extent, progression of gliomas, in a rat model. [ABSTRACT FROM AUTHOR]
Copyright of Nutrition & Cancer is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:01635581
DOI:10.1080/01635581.2013.789541